|
🐜
|
KRAS and BRAF mutations in advanced colorectal cancer are associated with poor prognosis but do not preclude benefit from oxaliplatin or irinotecan: results from the MRC FOCUS trial.
9 auth.
S. Richman,
M. Seymour,
P. Chambers,
F. Elliott,
C. Daly,
A. Meade,
...
G. Taylor,
J. Barrett,
P. Quirke
|
9 |
2009 |
9
🐜
|
|
🐜
|
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer
30 auth.
J. Burn,
A. Gerdes,
F. Macrae,
J. Mecklin,
G. Moeslein,
Sylviane Olschwang,
D. Eccles,
David Evans,
E. Maher,
L. Bertario,
M. Bisgaard,
Malcolm G Dunlop,
Judy Wc Ho,
Shirley V Hodgson,
A. Lindblom,
...
J. Lubiński,
Patrick J. Morrison,
V. Murday,
R. Ramesar,
L. Side,
Rodney J. Scott,
Huw J W Thomas,
H. Vasen,
Gail Barker,
G. Crawford,
F. Elliott,
M. Movahedi,
K. Pylvänäinen,
J. Wijnen,
R. Fodde
|
9 |
2016 |
9
🐜
|
|
🐜
|
Discovery of common and rare genetic risk variants for colorectal cancer
199 auth.
J. Huyghe,
Stephanie A. Bien,
T. Harrison,
H. Kang,
Sai Chen,
S. Schmit,
D. Conti,
C. Qu,
Jihyoun Jeon,
C. Edlund,
Peyton Greenside,
Michael Wainberg,
F. Schumacher,
Joshua D. Smith,
D. Levine,
...
Sarah C. Nelson,
Nasa Sinnott-Armstrong,
D. Albanes,
M. Alonso,
K. Anderson,
C. Arnau-Collell,
V. Arndt,
C. Bamia,
B. Banbury,
J. Baron,
S. Berndt,
S. Bézieau,
D. Bishop,
J. Boehm,
H. Boeing,
H. Brenner,
S. Brezina,
S. Buch,
D. Buchanan,
A. Burnett-Hartman,
Katja Butterbach,
B. Caan,
P. Campbell,
C. Carlson,
S. Castellví-Bel,
A. Chan,
J. Chang-Claude,
S. Chanock,
M. Chirlaque,
Sang‐Hee Cho,
C. Connolly,
A. Cross,
Katarina Ćuk,
Keith Curtis,
A. de la Chapelle,
K. Doheny,
D. Duggan,
D. Easton,
S. Elias,
F. Elliott,
D. English,
E. Feskens,
J. Figueiredo,
Rocky Fischer,
L. FitzGerald,
D. Forman,
M. Gala,
S. Gallinger,
W. Gauderman,
G. Giles,
E. Gillanders,
Jian Gong,
P. Goodman,
W. Grady,
J. Grove,
A. Gsur,
M. Gunter,
R. Haile,
J. Hampe,
H. Hampel,
Sophia Harlid,
R. Hayes,
P. Hofer,
M. Hoffmeister,
J. Hopper,
W. Hsu,
Wen-Yi Huang,
T. Hudson,
D. Hunter,
G. Ibáñez‐Sanz,
G. Idos,
R. Ingersoll,
R. Jackson,
E. Jacobs,
M. Jenkins,
A. Joshi,
C. Joshu,
T. Keku,
T. Key,
H. Kim,
Emiko Kobayashi,
L. Kolonel,
C. Kooperberg,
T. Kühn,
S. Küry,
S. Kweon,
S. Larsson,
C. Laurie,
L. Le Marchand,
S. Leal,
S. C. Lee,
F. Lejbkowicz,
M. Lemire,
Christopher I. Li,
Li Li,
W. Lieb,
Yi Lin,
A. Lindblom,
N. Lindor,
H. Ling,
T. Louie,
S. Männistö,
S. Markowitz,
V. Martín,
G. Masala,
C. McNeil,
Marilena Melas,
R. Milne,
Lorena Moreno,
N. Murphy,
Robin Myte,
A. Naccarati,
P. Newcomb,
K. Offit,
S. Ogino,
N. Onland-Moret,
B. Pardini,
P. Parfrey,
R. Pearlman,
Vittorio Perduca,
P. Pharoah,
M. Pinchev,
E. Platz,
R. Prentice,
E. Pugh,
L. Raskin,
G. Rennert,
H. Rennert,
E. Riboli,
M. Rodríguez-Barranco,
Jane M. Romm,
L. Sakoda,
C. Schafmayer,
R. Schoen,
D. Seminara,
M. Shah,
T. Shelford,
M. Shin,
K. Shulman,
S. Sieri,
M. Slattery,
M. Southey,
Z. Stadler,
C. Stegmaier,
Yu-Ru Su,
C. Tangen,
S. Thibodeau,
Duncan C. Thomas,
Sushma S. Thomas,
A. Toland,
A. Trichopoulou,
C. Ulrich,
D. J. Van Den Berg,
F. V. van Duijnhoven,
B. van Guelpen,
H. V. van Kranen,
J. Vijai,
K. Visvanathan,
P. Vodicka,
L. Vodickova,
Veronika Vymetálková,
K. Weigl,
S. Weinstein,
E. White,
Aung Ko Win,
C. Wolf,
A. Wolk,
M. Woods,
A. Wu,
Syed H Zaidi,
B. Zanke,
Qing Zhang,
W. Zheng,
P. Scacheri,
J. Potter,
M. Bassik,
A. Kundaje,
G. Casey,
V. Moreno,
G. Abecasis,
D. Nickerson,
S. Gruber,
L. Hsu,
U. Peters
|
8 |
2018 |
8
🐜
|
|
🐜
|
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
33 auth.
J. Burn,
A. Gerdes,
F. Macrae,
J. Mecklin,
G. Moeslein,
S. Olschwang,
D. Eccles,
David Evans,
Eamonn R. Maher,
L. Bertario,
M. Bisgaard,
Malcolm G Dunlop,
Judy Wc Ho,
Shirley V Hodgson,
A. Lindblom,
...
J. Lubiński,
Patrick J. Morrison,
V. Murday,
R. Ramesar,
L. Side,
Rodney J. Scott,
Huw J W Thomas,
Hans F. A. Vasen,
Gail Barker,
G. Crawford,
F. Elliott,
M. Movahedi,
K. Pylvanainen,
J. Wijnen,
R. Fodde,
Henry T. Lynch,
J. C. Mathers,
D. T. Bishop
|
8 |
2011 |
8
🐜
|
|
🐜
|
Predictive biomarkers of chemotherapy efficacy in colorectal cancer: results from the UK MRC FOCUS trial.
12 auth.
M. Braun,
S. Richman,
P. Quirke,
C. Daly,
J. Adlard,
F. Elliott,
...
J. Barrett,
P. Selby,
A. Meade,
R. Stephens,
M. Parmar,
M. Seymour
|
8 |
2008 |
8
🐜
|
|
🐜
|
Serum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma.
20 auth.
J. Newton-Bishop,
S. Beswick,
J. Randerson-Moor,
Yu-Mei Chang,
P. Affleck,
F. Elliott,
M. Chan,
Susan Leake,
Birute Karpavicius,
Sue Haynes,
...
Kairen Kukalizch,
L. Whitaker,
S. Jackson,
E. Gerry,
C. Nolan,
Chandra Bertram,
J. Marsden,
D. E. Elder,
J. Barrett,
D. Bishop
|
7 |
2009 |
7
🐜
|
|
🐜
|
Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial
34 auth.
J. Burn,
H. Sheth,
F. Elliott,
L. Reed,
F. Macrae,
J. Mecklin,
G. Möslein,
F. McRonald,
L. Bertario,
D. Evans,
A. Gerdes,
J. Ho,
A. Lindblom,
P. Morrison,
J. Rashbass,
...
R. Ramesar,
T. Seppälä,
H. Thomas,
K. Pylvänäinen,
G. Borthwick,
J. Mathers,
D. Bishop,
A. Boussioutas,
C. Brewer,
J. Cook,
D. Eccles,
A. Ellis,
S. Hodgson,
J. Lubiński,
E. Maher,
M. Porteous,
J. Sampson,
R. Scott,
L. Side
|
7 |
2020 |
7
🐜
|
|
🐜
|
A Randomized Placebo-Controlled Prevention Trial of Aspirin and/or Resistant Starch in Young People with Familial Adenomatous Polyposis
17 auth.
J. Burn,
D. Bishop,
P. Chapman,
F. Elliott,
L. Bertario,
M. Dunlop,
D. Eccles,
A. Ellis,
D. Evans,
R. Fodde,
...
E. Maher,
G. Möslein,
H. Vasen,
J. Coaker,
R. Phillips,
S. Bülow,
J. Mathers
|
7 |
2011 |
7
🐜
|
|
🐜
|
MRE11 expression is predictive of cause-specific survival following radical radiotherapy for muscle-invasive bladder cancer.
17 auth.
A. Choudhury,
Louisa Nelson,
M. Teo,
S. Chilka,
S. Bhattarai,
C. Johnston,
F. Elliott,
J. Lowery,
Claire F. Taylor,
M. Churchman,
...
J. Bentley,
M. Knowles,
P. Harnden,
R. Bristow,
D. Bishop,
A. Kiltie,
A. Kiltie
|
7 |
2010 |
7
🐜
|
|
🐜
|
A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer
82 auth.
L. Kiemeney,
P. Sulem,
Søren Besenbacher,
S. Vermeulen,
A. Sigurdsson,
G. Thorleifsson,
D. Gudbjartsson,
S. Stacey,
J. Gudmundsson,
C. Zanon,
J. Kostic,
G. Másson,
Hjordis Bjarnason,
S. Palsson,
Oskar B Skarphedinsson,
...
S. A. Gudjonsson,
J. Witjes,
A. Grotenhuis,
G. Verhaegh,
D. Bishop,
S. Sak,
A. Choudhury,
F. Elliott,
J. Barrett,
C. Hurst,
P. J. Verdier,
Charlotta Ryk,
P. Rudnai,
E. Gurzău,
K. Koppová,
P. Vineis,
P. Vineis,
S. Polidoro,
S. Polidoro,
S. Guarrera,
S. Guarrera,
C. Sacerdote,
M. Campagna,
D. Placidi,
C. Arici,
M. P. Zeegers,
M. P. Zeegers,
E. Kellen,
B. Gutiérrez,
José I Sanz-Velez,
Manuel Sanchez‐Zalabardo,
Gabriel Valdivia,
M. García-Prats,
J. Hengstler,
M. Blaszkewicz,
H. Dietrich,
R. Ophoff,
R. Ophoff,
L. Berg,
K. Alexíusdóttir,
K. Kristjánsson,
G. Geirsson,
S. Nikulasson,
V. Pétursdóttir,
A. Kong,
T. Thorgeirsson,
N. Mungan,
A. Lindblom,
M. A. Es,
S. Porru,
F. Buntinx,
F. Buntinx,
K. Golka,
J. Mayordomo,
Rajiv Kumar,
G. Matullo,
G. Matullo,
G. Steineck,
A. Kiltie,
K. Aben,
E. Jonsson,
U. Thorsteinsdóttir,
U. Thorsteinsdóttir,
M. Knowles,
T. Rafnar,
K. Stefansson,
K. Stefánsson
|
7 |
2010 |
7
🐜
|
|
🐜
|
Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome.
28 auth.
J. Burn,
D. Bishop,
J. Mecklin,
F. Macrae,
G. Möslein,
S. Olschwang,
M. Bisgaard,
R. Ramesar,
D. Eccles,
Eamonn R. Maher,
L. Bertario,
H. Jarvinen,
A. Lindblom,
D. Evans,
J. Lubiński,
...
Patrick J. Morrison,
Judy W. C. Ho,
H. Vasen,
L. Side,
H. Thomas,
Rodney J. Scott,
M. Dunlop,
Gail Barker,
F. Elliott,
J. Jass,
R. Fodde,
H. Lynch,
J. Mathers
|
7 |
2008 |
7
🐜
|
